ATE497169T1 - Verfahren zur unterscheidung von metaplasien von neoplastischen oder präneoplastischen läsionen - Google Patents

Verfahren zur unterscheidung von metaplasien von neoplastischen oder präneoplastischen läsionen

Info

Publication number
ATE497169T1
ATE497169T1 AT07106444T AT07106444T ATE497169T1 AT E497169 T1 ATE497169 T1 AT E497169T1 AT 07106444 T AT07106444 T AT 07106444T AT 07106444 T AT07106444 T AT 07106444T AT E497169 T1 ATE497169 T1 AT E497169T1
Authority
AT
Austria
Prior art keywords
neoplastic
hpv
metaplasia
differentiating
lesions
Prior art date
Application number
AT07106444T
Other languages
English (en)
Inventor
Peter Martin
Knebel Doeberitz Magnus Von
Ruediger Ridder
Original Assignee
Mtm Lab Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mtm Lab Ag filed Critical Mtm Lab Ag
Application granted granted Critical
Publication of ATE497169T1 publication Critical patent/ATE497169T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/708—Specific hybridization probes for papilloma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57411—Specifically defined cancers of cervix
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G01N2333/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Geophysics And Detection Of Objects (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Paper (AREA)
AT07106444T 2002-04-09 2003-04-08 Verfahren zur unterscheidung von metaplasien von neoplastischen oder präneoplastischen läsionen ATE497169T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP20020007954 EP1369694A1 (de) 2002-04-09 2002-04-09 Verfahren zur Unterscheidung zwischen Metaplasien und neoplastischen oder präneoplastischen Läsionen

Publications (1)

Publication Number Publication Date
ATE497169T1 true ATE497169T1 (de) 2011-02-15

Family

ID=29433069

Family Applications (2)

Application Number Title Priority Date Filing Date
AT07106444T ATE497169T1 (de) 2002-04-09 2003-04-08 Verfahren zur unterscheidung von metaplasien von neoplastischen oder präneoplastischen läsionen
AT03758090T ATE382863T1 (de) 2002-04-09 2003-04-08 Verfahren zur unterscheidung von metaplasien von neoplastischen oder präneoplastischen läsionen

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT03758090T ATE382863T1 (de) 2002-04-09 2003-04-08 Verfahren zur unterscheidung von metaplasien von neoplastischen oder präneoplastischen läsionen

Country Status (10)

Country Link
US (6) US7422859B2 (de)
EP (3) EP1369694A1 (de)
JP (2) JP4290118B2 (de)
CN (1) CN1643378A (de)
AT (2) ATE497169T1 (de)
AU (1) AU2003274105A1 (de)
DE (2) DE60318415T2 (de)
ES (2) ES2360342T3 (de)
MX (1) MXPA04009584A (de)
WO (1) WO2004005927A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1388734B1 (de) 2002-08-01 2004-03-03 MTM Laboratories AG Verfahren für Lösung-basierte Diagnose
EP1369694A1 (de) 2002-04-09 2003-12-10 MTM Laboratories AG Verfahren zur Unterscheidung zwischen Metaplasien und neoplastischen oder präneoplastischen Läsionen
EP1422526A1 (de) 2002-10-28 2004-05-26 MTM Laboratories AG Verfahren zur verbesserten Diagnose von Dysplasien
US7972776B2 (en) * 2005-11-15 2011-07-05 Oncohealth Corporation Protein chips for HPV detection
US7732166B2 (en) 2005-11-15 2010-06-08 Oncohealth Corporation Detection method for human pappilomavirus (HPV) and its application in cervical cancer
WO2010129821A1 (en) 2009-05-07 2010-11-11 Oncohealth Corporation Identification of high grade or ≥cin2 for early stages and late stages detection, screening, and diagnosis of human papillomavirus (hpv) and hpv-associated cancers
US8278056B2 (en) * 2008-06-13 2012-10-02 Oncohealth Corp. Detection of early stages and late stages HPV infection
US8968995B2 (en) * 2008-11-12 2015-03-03 Oncohealth Corp. Detection, screening, and diagnosis of HPV-associated cancers
US7838215B2 (en) 2007-09-25 2010-11-23 Canvir, Inc. Advanced cervical cell screening methods
CA2726396C (en) * 2008-04-17 2019-03-19 Qiagen Gaithersburg, Inc. Compositions, methods, and kits using synthetic probes for determining the presence of a target nucleic acid
US8728745B2 (en) * 2008-09-04 2014-05-20 Ventana Medical Sysems, Inc. Method for prediction of the progression risk of tumors
EP2521914A4 (de) 2010-01-08 2013-07-10 Oncohealth Corp Zellbasierte hpv-immuntests mit hoher durchlaufleistung zur diagnose und abtastung von hpv-assoziierten krebsen
WO2013066491A1 (en) * 2011-09-09 2013-05-10 Amgen Inc. Use of human papillomavirus status in establishing use of an agent that binds egfr in the treatment of cancer
CN103076453B (zh) * 2012-12-24 2015-04-15 何以丰 P16免疫细胞化学试剂盒及其制备用多肽序列
CA2946534A1 (en) * 2014-04-28 2015-11-05 Arizona Board Of Regents On Behalf Of Arizona State University Novel methods, bioassays, and biomarkers for hpv-related conditions
WO2016207414A1 (en) * 2015-06-25 2016-12-29 Universitaet Des Saarlandes Improved diagnostic method for hpv-induced cancer and precancerous lesion screening and diagnosis
EP3921441A1 (de) * 2019-02-08 2021-12-15 Charité - Universitätsmedizin Berlin Verfahren zur bestimmung des schweregrades von durch das humane papillomavirus (hpv) induzierter dysplasie

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281061A (en) * 1979-07-27 1981-07-28 Syva Company Double antibody for enhanced sensitivity in immunoassay
US6316208B1 (en) * 1994-01-07 2001-11-13 Memorial Sloan-Kettering Cancer Center Methods for determining isolated p27 protein levels and uses thereof
US6033847A (en) * 1995-02-06 2000-03-07 St. Jude Children's Research Hospital InK4c-p18 and InK4d-p19, inhibitors of cyclin-dependent kinases CDK4 and CDK6, and uses thereof
US5723313A (en) 1995-09-27 1998-03-03 St. Jude Children's Research Hospital ARF-p19, a novel regulator of the mammalian cell cycle
US6407062B1 (en) 1995-09-27 2002-06-18 St. Jude Children's Research Hospital ARF-P19, a novel regulator of the mammalian cell cycle
US5858683A (en) * 1996-08-30 1999-01-12 Matritech, Inc. Methods and compositions for the detection of cervical cancer
US6303323B1 (en) 1997-10-21 2001-10-16 Cancer Research Campaign Technology Limited Detection of dysplastic or neoplastic cells using anti-MCM5 antibodies
HUP0004134A2 (en) 1997-10-21 2001-03-28 Cancer Res Campaign Tech Determination of cellular growth abnormality
EP1388734B1 (de) 2002-08-01 2004-03-03 MTM Laboratories AG Verfahren für Lösung-basierte Diagnose
DE19829473C2 (de) * 1998-07-01 2000-08-10 Magnus Von Knebel Doeberitz Ch Verfahren zur frühen Diagnose von Carcinomen
DE19957689A1 (de) 1999-11-30 2001-06-13 Deutsches Krebsforsch Proteaseresistenter Tumorsuppressor p14(ARF)
GB0018140D0 (en) * 2000-07-24 2000-09-13 Medical Res Council Screening for abnormalities
DE10063179A1 (de) * 2000-12-18 2002-06-20 Bayer Ag Verfahren zur spezifischen Detektion von Tumorzellen und ihren Vorstufen in Gebärmutterhalsabstrichen durch simultane Messung von mindestens zwei verschiedenen molekularen Markern
ES2654909T3 (es) * 2002-01-07 2018-02-15 Pretect As Método para detectar ARNm del virus del papiloma humano
EP1369694A1 (de) 2002-04-09 2003-12-10 MTM Laboratories AG Verfahren zur Unterscheidung zwischen Metaplasien und neoplastischen oder präneoplastischen Läsionen
EP1387173A1 (de) 2002-07-29 2004-02-04 MTM Laboratories AG Verfahren zur verbesserten Diagnose von Zervixläsionen basierend auf dem Nachweis von INK4a Genprodukten
WO2004013631A2 (en) 2002-07-29 2004-02-12 Mtm Laboratories Ag Compositions and methods for diagnosis and therapy of cancer
EP1422526A1 (de) 2002-10-28 2004-05-26 MTM Laboratories AG Verfahren zur verbesserten Diagnose von Dysplasien
US7361460B2 (en) 2003-04-11 2008-04-22 Digene Corporation Approach to molecular diagnosis of human papillomavirus-related diseases
US8728745B2 (en) 2008-09-04 2014-05-20 Ventana Medical Sysems, Inc. Method for prediction of the progression risk of tumors

Also Published As

Publication number Publication date
US8043819B2 (en) 2011-10-25
EP1493032B1 (de) 2008-01-02
US7422859B2 (en) 2008-09-09
US20190177804A1 (en) 2019-06-13
DE60318415D1 (de) 2008-02-14
US10246751B2 (en) 2019-04-02
MXPA04009584A (es) 2005-01-11
EP1369694A1 (de) 2003-12-10
DE60318415T2 (de) 2009-01-08
ES2360342T3 (es) 2011-06-03
EP1821102B1 (de) 2011-01-26
DE60335922D1 (de) 2011-03-10
US8815520B2 (en) 2014-08-26
US20050255468A1 (en) 2005-11-17
JP4809408B2 (ja) 2011-11-09
JP4290118B2 (ja) 2009-07-01
WO2004005927A1 (en) 2004-01-15
JP2005523039A (ja) 2005-08-04
AU2003274105A1 (en) 2004-01-23
ATE382863T1 (de) 2008-01-15
US10822660B2 (en) 2020-11-03
US20090104609A1 (en) 2009-04-23
US11155878B2 (en) 2021-10-26
US20140308660A1 (en) 2014-10-16
US20170268068A1 (en) 2017-09-21
US20120052510A1 (en) 2012-03-01
EP1493032A1 (de) 2005-01-05
ES2297209T3 (es) 2008-05-01
CN1643378A (zh) 2005-07-20
JP2009000127A (ja) 2009-01-08
EP1821102A1 (de) 2007-08-22

Similar Documents

Publication Publication Date Title
ATE382863T1 (de) Verfahren zur unterscheidung von metaplasien von neoplastischen oder präneoplastischen läsionen
RU2008142996A (ru) Магниторезистивный датчик в качестве датчика температуры
ATE538213T1 (de) Vorrichtung und verfahren zum identifizieren genomischer dna von organismen
DE602005015299D1 (de) Verfahren, chip, vorrichtung und integriertes system zum nachweis biologischer partikel
DE602006019111D1 (de) Verfahren zur isolierung von analyten aus einer probe
CY1119972T1 (el) Προσδιορισμος για αντισωματα ιου jc
WO2008124847A3 (en) Methods and computer systems for identifying target-specific sequences for use in nanoreporters
DE69816286D1 (de) Verfahren zur Erkennung von Nukleinsäuremethylierungen durch AFLP
ATE516370T1 (de) Verfahren zur erfassung von krebszellen unter verwendung eines virus
ATE441861T1 (de) Verfahren zum nachweis von analyten auf grundlage von evaneszenzbelichtung und auf streuung beruhender nachweis von nanopartikelsondenkomplexen
ATE545031T1 (de) Verfahren unter beteiligung von datenmustern, wie etwa spektralen biomarkern
DE602004021185D1 (de) Auf bio-barcodes beruhender nachweis von zielanalyten
WO2007030324A3 (en) Sample identification system having plural readers
ATE452990T1 (de) Verfahren zur zählung und identifikation von mikroorganismen
ATE365908T1 (de) Vorrichtung und verfahren zur entnahme von proben
MY145455A (en) Diagnostic biomolecule(s)
DE59712894D1 (de) Verfahren zum nachweis klinisch relevanter veränderungen der dns-sequenz des ki-ras-onkogens, seine verwendung und testkit zur früherkennung von tumoren
ATE538217T1 (de) Erkennung von ektopischen schwangerschaften
ATE408710T1 (de) Nachweis von legionella durch ein pcr und fret verwendendes verfahren
DE60005813D1 (de) Verfahren und vorrichtung zur detektion der veränderung optischer eigenschaften einer probe in einem analyseprozess
ATE394675T1 (de) Verfahren zum nachweis von brustkrebs
DE60121547D1 (de) Electrochemisches verfahren zum nachweis von nukleinsäuren
DE602004019180D1 (de) Methode zur Identifizierung von unbekannten Proteinen mittels zwei-dimensionaler Auftrennung und Verwendung von Markern
ATE529745T1 (de) Verfahren zur bewertung des hautempfindlichkeitsniveaus durch verwendung von mit plattenepithelkarzinom zusammenhängendem antigen als indikation
GR3036316T3 (en) Method, test element and test kit for semi-quantitative detection of target nucleic acid.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties